Botanix Ltd (ASX:BOT) CEO Dr Howie McKibbon sits down with Proactive's Tylah Tully live from the ASX Small and Mid Cap Conference in September 2024. Chaired by Phoenix-based pharmaceutical magnate Vince Ippolito, the company is on a mission to create innovative solutions for common (yet overlooked) skin diseases and infections. Amid growing demand for these kinds of treatments, Botanix has assembled a team of dermatology, clinical research and commercialisation experts to further its portfolio. According to Dr McKibbon, the company wants to use its clinical expertise to deliver first-in-class treatments at the highest industry standards. #ProactiveInvestors #Botanix #ASX #Dermatology #ClinicalResearch #Commercialisation #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews